ETON
Eton Pharmaceuticals Inc

5,635
Loading...
Loading...
News
all
press releases
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Investors need to pay close attention to ETON stock based on the movements in the options market lately.
Zacks·13d ago
News Placeholder
More News
News Placeholder
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -900.00% and +13.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Eton Pharmaceuticals (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks·4mo ago
News Placeholder
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
Zacks·5mo ago
News Placeholder
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
chainwire·5mo ago
News Placeholder
eToro files for NASDAQ IPO under symbol ETOR
Investing.com -- On Monday, eToro Group Ltd. took a significant step towards becoming a publicly-traded company by filing for an Initial Public Offering (IPO) with the Securities and Exchange Commission (SEC). The company is set to offer Class A common shares on the Nasdaq Global Market, although the number of shares and the price range for the offering have not been disclosed. eToro, which has not previously had a public market for its Class A common shares, will trade under the ticker symbol "ETOR".
investing.com·7mo ago
News Placeholder
Earnings Outlook For Eton Pharmaceuticals
read more...
Benzinga·11mo ago
News Placeholder
Critical Insights From Eton Pharmaceuticals Analyst Ratings: What You Need To Know
Latest Ratings for ETON DateFirmActionFromTo Mar 2021HC Wainwright & Co.MaintainsBuy Jan 2021HC Wainwright & Co.MaintainsBuy Sep 2020HC Wainwright & Co.MaintainsBuy View More Analyst Ratings...
Benzinga·11mo ago
News Placeholder
Craig-Hallum Sticks to Its Buy Rating for Eton Pharmaceuticals (ETON)
In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Eton Pharmaceuticals (ETON Research Report). The com...
TipRanks Financial Blog·1y ago

Latest ETON News

View

Advertisement|Remove ads.

Advertisement|Remove ads.